CohBar, Inc.
(NASDAQ : CWBR)

( )
CWBR PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
REGNRegeneron Pharmaceuticals, Inc. -1.85%731.862.6%$754.70m
AMGNAmgen, Inc. -1.23%230.941.4%$608.51m
MRNAModerna, Inc. -0.37%125.150.0%$589.94m
BIIBBiogen, Inc. 0.22%262.261.8%$580.04m
GILDGilead Sciences, Inc. -0.76%64.951.0%$550.05m
VRTXVertex Pharmaceuticals, Inc. -1.12%298.631.9%$429.92m
ILMNIllumina, Inc. -2.65%212.723.2%$410.84m
SNSSSunesis Pharmaceuticals, Inc. -1.47%4.020.7%$281.01m
SAVACassava Sciences, Inc. 3.37%42.350.0%$189.68m
BNTXBioNTech SE 0.25%137.530.0%$109.40m
TECHBio-Techne Corp. 0.17%309.084.5%$100.77m
BMRNBioMarin Pharmaceutical, Inc. 2.18%91.484.2%$95.92m
NVAXNovavax, Inc. -3.32%18.0875.6%$79.49m
PRTAProthena Corp. Plc 0.79%58.5713.8%$79.21m
SNTISenti Biosciences, Inc. 23.49%6.520.0%$78.99m

Company Profile

CohBar, Inc. engages in the research and development of mitochondria-based therapeutics. It focuses on treatments of diseases, which include diabetes, obesity, fatty liver disease and non-alcoholic steatohepatitis, cancer, Alzheimer's disease, and atherosclerosis. The company was founded by Nir Barzilai, Pinchas Cohen, David Sinclair, John Amatruda, and Laura Cobb on October 19, 2007 and is headquartered in Menlo Park, CA.